Skip to main content
. 2019 Feb 15;11(2):230. doi: 10.3390/cancers11020230

Table 2.

Primary tumor and tumor vascular thrombosis (TVT) response according to dose-fractionation regimens and pre- and post-treatment (Tx).

Response Dose-Fractionation Regimen, n (%) p Value * Pre-Tx to PBT Site, n (%) p Value * Post-Tx to PBT Site, n (%) p Value *
Regimen A Regimen B Regimen C No Yes No Yes
Primary tumor CR 16 (40.0) 51 (85.0) 132 (92.3) <0.001 47 (90.4) 152 (79.6) 0.405 174 (89.2) 25 (53.1) <0.001
(n = 243) PR 18 (45.0) 6 (10.0) 6 (4.2) 4 (7.7) 26 (13.6) 16 (8.2) 14 (29.2)
SD 6 (15.02) 2 (3.3) 5 (3.5) 1 (1.9) 12 (6.3) 5 (2.6) 1 (2.1)
PD 0 (0.0) 1 (1.7) 0 (0.0) 0 (0.0) 1 (0.5) 0 (0.0) 1 (2.1)
TVT CR 9 (31.0) 15 (75.0) 6 (60.0) 0.021 3 (42.9) 27 (51.9) 0.877 15 (60.0) 15 (44.1) 0.610
(n = 59) PR 12 (41.4) 3 (15.0) 3 (30.0) 3 (42.9) 15 (28.9) 7 (28.0) 11 (32.4)
SD 8 (27.6) 1 (5.0) 1 (10.0) 1 (14.2) 9 (17.3) 3 (12.0) 7 (20.6)
PD 0 (0.0) 1 (5.0) 0 (0.0) 0 (0.0) 1 (1.9) 0 (0.0) 1 (2.9)

Abbreviations: CR, complete response; PR, partial response; SD, stable disease; PD, progressive disease; the others are the same as Table 1. * Fisher’s exact test.